ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................JBDM Ver 0.1.63 (23 May 2017) - 2999001/03002008CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120181024W173deBibliographieenBibliographyfrBibliographieEP15188438.4201103112016090820170111enenen339974 P20100311US2018102420184320160406201614201808152018332018022320181024201843A61K 31/535 20060101AFI20180208BHEP A61K 31/4525 20060101ALI20180208BHEP A61K 31/4453 20060101ALI20180208BHEP A61K 31/453 20060101ALI20180208BHEP A61K 31/5375 20060101ALI20180208BHEP A61K 31/495 20060101ALI20180208BHEP A61K 31/496 20060101ALI20180208BHEP A61K 31/40 20060101ALI20180208BHEP A61K 31/404 20060101ALI20180208BHEP C07D 317/54 20060101ALI20180208BHEP C07D 317/60 20060101ALI20180208BHEP C07D 403/14 20060101ALI20180208BHEP C07D 405/06 20060101ALI20180208BHEP C07C 235/34 20060101ALI20180208BHEP C07C 235/36 20060101ALI20180208BHEP C07D 211/16 20060101ALI20180208BHEP C07D 307/52 20060101ALI20180208BHEP A61P 29/00 20060101ALI20180208BHEP A61P 37/00 20060101ALI20180208BHEP A61K 31/445 20060101ALI20180208BHEP deAMIDVERBINDUNGEN ALS RORYT-MODULATOREN UND VERWENDUNGEN DAVONenAMIDO COMPOUNDS AS RORYT MODULATORS AND USES THEREOFfrCOMPOSÉS D'AMIDO COMME MODULATEURS RORYT ET LEURS UTILISATIONSWO-A2-2006/007486NARESH KUMAR ET AL: "The Benezenesulfonamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trif luoro-1-hydroxy-1-(trifluoromethyl)ethyl]p henyl]-benzenesulfonamide] is a Novel Retinoic Acid Receptor-Related Orphan Receptor-alpha/gamma Inverse Agonist", MOLECULAR PHARMACOLOGY, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 77, no. 2, 1 February 2010 (2010-02-01), pages 228-236, XP002645391, ISSN: 0026-895X, DOI: 10.1124/MOL.109.060905 [retrieved on 2009-11-03]KELIN LI ET AL: "Chemical Libraries via Sequential C-H Functionalization of Phenols", JOURNAL OF COMBINATORIAL CHEMISTRY, vol. 10, no. 2, 1 March 2008 (2008-03-01), pages 170-174, XP055073472, ISSN: 1520-4766, DOI: 10.1021/cc700150qJun R Huh: "Identification of Potent and Selective Diphenylpropanamide ROR[gamma] Inhibitors", ACS Med. Chem. Lett. 2013, 4, 6 December 2012 (2012-12-06), pages 79-84, XP055073467, DOI: 10.1021/ml300286h| Retrieved from the Internet: URL:http://pubs.acs.org/doi/pdf/10.1021/ml 300286h [retrieved on 2013-07-30]PASHA M. KHAN ET AL: "Small molecule amides as potent ROR-[gamma] selective modulators", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 23, no. 2, 1 January 2013 (2013-01-01), pages 532-536, XP055073469, ISSN: 0960-894X, DOI: 10.1016/j.bmcl.2012.11.02511753726.6255808720110311Littman, Dan29 Washington Square West Apartment No. 14DNew York, NY 1001 1USHuh, Jun, R.435 Riverside Drive No. 81New York, NY 10025USHuang, Wenwei317 Oak Knoll TerraceRockville, MarylandUSHuang, Ruili514 Jacala TerraceRockville, MD 20850USEnglund, Erika, Elaine2900 Connecticut Avenue NW Apt No. 245Washington, DC 20008USNew York University101388096NYU-P1466EPD170 Washington Square SouthNew York, NY 10012USThe Government of The United States of America, as represented by The Secretary, Department of Health and Human Services101394473NYU-P1466EPD1National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard, Suite 325Rockville, MD 20852-3804USTeuten, Andrew John101299088Sagittarius IP Three Globeside Fieldhouse LaneMarlow, Buckinghamshire SL7 1HZGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTR